Cambridge Biocapital, a strategic advisory firm distinguished by its deep roots in the Cambridge life sciences supercluster and extensive experience across premier global innovation hubs, today emerges from stealth announcing a significant operational expansion. This development is marked by the firm’s key participation in HEALTHPRENEURS, a €1.34M flagship project funded by the European Institute of Innovation and Technology (EIT) Health, designed to accelerate health technology entrepreneurship across Europe.
Building on an established track record where its founder, Andrea Martos Esteban, PhDc, has been instrumental in advising high-potential academic research projects and university spinouts, Cambridge Biocapital is now formalising and scaling its bespoke advisory services, as well as expanding the team and Board of Directors. The firm partners with universities, research institutions and governments offering hands on expertise and training to navigate the intricate journey from scientific discovery to commercialisation within the dynamic life sciences sector.
Cambridge Biocapital’s involvement in HEALTHPRENEURS underscores its commitment to fostering a new generation of health innovators. This EIT Higher Education Initiative is dedicated to significantly enhancing the innovation capacity of Higher Education Institutions (HEIs) throughout Europe, focusing on cultivating entrepreneurial mindsets and robust support structures within the health, sports, and nutrition domains.
"The formalisation of Cambridge Biocapital’s broader operational scope, crystallised by our engagement with the HEALTHPRENEURS initiative, represents a commitment to unlock and accelerate the immense potential of European health and life science innovation. This is a tremendous opportunity to strengthen the collaborative fabric that connects the continent's innovation community and to accelerate the journey of groundbreaking ideas from lab to market. We are honoured to play our part in this pivotal initiative, whilst doubling efforts to expand the value for our current clients and partners.” - Andrea Martos Esteban - Partner, Founder, Cambridge Biocapital
Contact
Andrea Martos Esteban, Partner
Email - comms@cambridgebiocapital.com
About Cambridge Biocapital
Cambridge Biocapital is the premier strategic advisory firm dedicated to navigating the complex landscape at the intersection of life sciences innovation, investment, and commercialisation. In an environment defined by rapid scientific advancement, complex funding cycles, and evolving market dynamics, securing expert guidance is critical. We partner with universities, research institutions and governments to unlock the value of scientific discovery and accelerate translation. We provide specialised insights, strategic counsel, training and the operational support necessary to achieve success in the global health and life sciences ecosystem.
Learn more at: https://www.cambridgebiocapital.com/
About HEALTHPRENEURS
HEALTHPRENEURS is a collaborative project under the EIT Higher Education Initiative, focused on boosting innovation and entrepreneurship in European Higher Education Institutions (HEIs), particularly in health, sports, and nutrition. Led by UCAM in Spain, the consortium includes partners from across Europe and aims to strengthen entrepreneurial skills, support startup development, and enhance regional innovation ecosystems.
Learn more at: https://eit-hei.eu/projects/healthpreneurs/
About EIT Health
EIT Health, established in 2015, is a ‘knowledge and innovation community’ (KIC) of the European Institute of Innovation and Technology (EIT). Focused on health and ageing, EIT Health operates on the principle of the ‘knowledge triangle,’ bringing together experts from business, research, and education to create an optimal environment for healthcare innovation.
Learn more at: https://eithealth.eu/